Emmanuel Mignot (born 1959 in Paris) is a sleep researcher and director of the Stanford Center for Sleep Sciences and Medicine, at Stanford University. Dr. Mignot is an authority on sleep research and medicine, and is mostly known for his work on narcolepsy. He is the Craig Reynolds Professor of Sleep Medicine at Stanford Medical School, Stanford University.[1]
Emmanuel Mignot
Born
1959 (age 64–65)
Paris, France
Education
Université Pierre and Marie Curie Necker-Enfants Malades, Université René Descartes École Normale Supérieure
Dr. Emmanuel Mignot completed his Science Doctorate in Molecular Pharmacology at the Université Pierre and Marie Curie and went to medical school at Necker-Enfants Malades, Université René Descartes, with subspecialisation in Psychiatry. Dr. Mignot is a former student of École Normale Supérieure (Ulm).
Following a postdoctoral fellowship at the Stanford Sleep Center, Mignot believed that understanding narcolepsy could lead to breakthrough in new understanding of sleep. He was appointed assistant professor of psychiatry and behavioral sciences at Stanford University in 1993, professor in 2001 and director of the Center for Sleep Sciences and Medicine in 2011, succeeding William C. Dement. Trained as a pharmacologist, he first deciphered the mode of action of modafinil, amphetamines, and antidepressants on narcolepsy symptoms,[2] work that was done in close collaboration with Dr. Seiji Nishino.
Starting in 1990, he isolated the gene causing canine narcolepsy in doberman and Labrador dogs. Ten years later, this led to the discovery that mutations in the hypocretin (orexin) receptor 2 cause canine narcolepsy,[3] and that human narcolepsy was caused by an immune mediated destruction of the hypocretin (orexin) producing cells in the brain [4] Parallel work performed by Mashashi Yanagisawa, Christopher Stinton and colleagues subsequently showed that hypocretin (orexin) deficient mice also have narcolepsy.[5]
The autoimmune destruction of hypocretin (orexin) neurons in the hypothalamus was later shown by Han and Mignot to be at least partially precipitated by influenza A infections, notably the H1N1 2009 pandemic strain,[6] complementing findings made in Northern Europe following the H1N1 Pandemrix vaccination campaign.[7]
Dr. Mignot identified genetic factors predisposing to human narcolepsy, such as human leukocyte antigen HLA DQB1*06:02 and other genes[8] and isolated the gene causing the methylopathy Autosomal Dominant Cerebelar Ataxia, Deafness and Narcolepsy (ADCA-DN), DNMT1.[9]
Dr. Mignot has received numerous research grants and honors, including National Sleep Foundation and National Institute of Health Research Awards, Howard Hughes Medical Institute Investigator and McKnight Neuroscience awards, the Narcolepsy Network[10] professional service award, the Drs. C. and F. Demuth 11th Award for Young Investigators in the Neurosciences, the WC Dement Academic Achievement Award in sleep disorders medicine, the CINP and ACNP awards in neuropharmacology and the Jacobaeus prize. He is an elected member of the Association of American Physicians and of the Institute of Medicine of the National Academy of Sciences. He is the co-author of more than 200 original scientific publications, and he serves on the editorial board of scientific journals in the field of sleep and biology research. Dr. Mignot is an active member of several professional and governmental organizations. He has been past president of the Sleep Research society, chair the National Center on Sleep Disorders Research Advisory board of the National institutes of Health and chair of the Board of Scientific Counselors of the National Institute of Mental Health. For 2023 he was awarded the Breakthrough Prize in Life Sciences for discovering that narcolepsy is caused by the loss of a small population of brain cells that make a wake-promoting substance, paving the way for the development of new treatments for sleep disorders.[11]
Bibliographyedit
This section needs expansion. You can help by adding to it. (March 2015)
Dr. Mignot has written many published works in the field of sleep medicine.[12][13]
^Mignot, Em. "Prof". Stanford. Retrieved 28 September 2013.
^Nishino S, Mignot E. Pharmacological aspects of human and canine narcolepsy. Prog. Neurobiol, 52: 27-78, 1997.
^Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, Qui X, de Jong P, Nishino S, Mignot E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98(3):365-76, 1999.
^Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) transmission is defective in human narcolepsy. Lancet, 355:39-40, 2000.
^Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, Yanagisawa M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell, 98: 437-451, 1999.
^Han F, Lin L, Warby SC, Faraco J, Li J, Dong SX, An P, Zhao L, Wang LH, Li QY, Yan H, Gao ZC, Yuan Y, Strohl KP, Mignot E (2011). Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol. ;70(3):410-7.
^Partinen M, Saarenpää-Heikkilä O, Ilveskoski I, Hublin C, Linna M, Olsén P, Nokelainen P, Alén R, Wallden T, Espo M, Rusanen H, Olme J, Sätilä H, Arikka H, Kaipainen P, Julkunen I, Kirjavainen T. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One. 2012;7(3):e33723.
^Sehgal A, Mignot E. Genetics of sleep and sleep disorders. Cell. 2011 Jul 22;146(2):194-207.
^Winkelmann J, Lin L, Schormair B, Kornum BR, Faraco J, Plazzi G, Melberg A, Cornelio F, Urban AE, Pizza F, Poli F, Grubert F, Wieland T, Graf E, Hallmayer J, Strom TM, Mignot E. Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy. Hum Mol Genet. 2012 May 15;21(10):2205-10.
^ https://profiles.stanford.edu/emmanuel-mignot. {{cite web}}: Missing or empty |title= (help)
emmanuel, mignot, this, article, includes, list, general, references, lacks, sufficient, corresponding, inline, citations, please, help, improve, this, article, introducing, more, precise, citations, september, 2012, learn, when, remove, this, message, born, 1. This article includes a list of general references but it lacks sufficient corresponding inline citations Please help to improve this article by introducing more precise citations September 2012 Learn how and when to remove this message Emmanuel Mignot born 1959 in Paris is a sleep researcher and director of the Stanford Center for Sleep Sciences and Medicine at Stanford University Dr Mignot is an authority on sleep research and medicine and is mostly known for his work on narcolepsy He is the Craig Reynolds Professor of Sleep Medicine at Stanford Medical School Stanford University 1 Emmanuel MignotBorn1959 age 64 65 Paris FranceEducationUniversite Pierre and Marie CurieNecker Enfants Malades Universite Rene DescartesEcole Normale SuperieureKnown forWork on narcolepsyMedical careerProfessionMedical doctorInstitutionsStanford Center for Sleep Sciences and MedicineSub specialtiesPsychiatryResearchSleep disorders Contents 1 Career 1 1 Awards 2 Bibliography 3 See also 4 References 5 Further reading 6 External linksCareer editDr Emmanuel Mignot completed his Science Doctorate in Molecular Pharmacology at the Universite Pierre and Marie Curie and went to medical school at Necker Enfants Malades Universite Rene Descartes with subspecialisation in Psychiatry Dr Mignot is a former student of Ecole Normale Superieure Ulm Following a postdoctoral fellowship at the Stanford Sleep Center Mignot believed that understanding narcolepsy could lead to breakthrough in new understanding of sleep He was appointed assistant professor of psychiatry and behavioral sciences at Stanford University in 1993 professor in 2001 and director of the Center for Sleep Sciences and Medicine in 2011 succeeding William C Dement Trained as a pharmacologist he first deciphered the mode of action of modafinil amphetamines and antidepressants on narcolepsy symptoms 2 work that was done in close collaboration with Dr Seiji Nishino Starting in 1990 he isolated the gene causing canine narcolepsy in doberman and Labrador dogs Ten years later this led to the discovery that mutations in the hypocretin orexin receptor 2 cause canine narcolepsy 3 and that human narcolepsy was caused by an immune mediated destruction of the hypocretin orexin producing cells in the brain 4 Parallel work performed by Mashashi Yanagisawa Christopher Stinton and colleagues subsequently showed that hypocretin orexin deficient mice also have narcolepsy 5 The autoimmune destruction of hypocretin orexin neurons in the hypothalamus was later shown by Han and Mignot to be at least partially precipitated by influenza A infections notably the H1N1 2009 pandemic strain 6 complementing findings made in Northern Europe following the H1N1 Pandemrix vaccination campaign 7 Dr Mignot identified genetic factors predisposing to human narcolepsy such as human leukocyte antigen HLA DQB1 06 02 and other genes 8 and isolated the gene causing the methylopathy Autosomal Dominant Cerebelar Ataxia Deafness and Narcolepsy ADCA DN DNMT1 9 Awards edit This section of a biography of a living person does not include any references or sources Please help by adding reliable sources Contentious material about living people that is unsourced or poorly sourced must be removed immediately Find sources Emmanuel Mignot news newspapers books scholar JSTOR March 2015 Learn how and when to remove this message Dr Mignot has received numerous research grants and honors including National Sleep Foundation and National Institute of Health Research Awards Howard Hughes Medical Institute Investigator and McKnight Neuroscience awards the Narcolepsy Network 10 professional service award the Drs C and F Demuth 11th Award for Young Investigators in the Neurosciences the WC Dement Academic Achievement Award in sleep disorders medicine the CINP and ACNP awards in neuropharmacology and the Jacobaeus prize He is an elected member of the Association of American Physicians and of the Institute of Medicine of the National Academy of Sciences He is the co author of more than 200 original scientific publications and he serves on the editorial board of scientific journals in the field of sleep and biology research Dr Mignot is an active member of several professional and governmental organizations He has been past president of the Sleep Research society chair the National Center on Sleep Disorders Research Advisory board of the National institutes of Health and chair of the Board of Scientific Counselors of the National Institute of Mental Health For 2023 he was awarded the Breakthrough Prize in Life Sciences for discovering that narcolepsy is caused by the loss of a small population of brain cells that make a wake promoting substance paving the way for the development of new treatments for sleep disorders 11 Bibliography editThis section needs expansion You can help by adding to it March 2015 Dr Mignot has written many published works in the field of sleep medicine 12 13 See also editNarcolepsy Hypersomnia Kleine Levin syndromeReferences edit Mignot Em Prof Stanford Retrieved 28 September 2013 Nishino S Mignot E Pharmacological aspects of human and canine narcolepsy Prog Neurobiol 52 27 78 1997 Lin L Faraco J Li R Kadotani H Rogers W Lin X Qui X de Jong P Nishino S Mignot E The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin orexin receptor 2 gene Cell 98 3 365 76 1999 Nishino S Ripley B Overeem S Lammers GJ Mignot E Hypocretin orexin transmission is defective in human narcolepsy Lancet 355 39 40 2000 Chemelli RM Willie JT Sinton CM Elmquist JK Scammell T Lee C Richardson JA Williams SC Xiong Y Kisanuki Y Fitch TE Nakazato M Hammer RE Saper CB Yanagisawa M Narcolepsy in orexin knockout mice molecular genetics of sleep regulation Cell 98 437 451 1999 Han F Lin L Warby SC Faraco J Li J Dong SX An P Zhao L Wang LH Li QY Yan H Gao ZC Yuan Y Strohl KP Mignot E 2011 Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China Ann Neurol 70 3 410 7 Partinen M Saarenpaa Heikkila O Ilveskoski I Hublin C Linna M Olsen P Nokelainen P Alen R Wallden T Espo M Rusanen H Olme J Satila H Arikka H Kaipainen P Julkunen I Kirjavainen T Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland PLoS One 2012 7 3 e33723 Sehgal A Mignot E Genetics of sleep and sleep disorders Cell 2011 Jul 22 146 2 194 207 Winkelmann J Lin L Schormair B Kornum BR Faraco J Plazzi G Melberg A Cornelio F Urban AE Pizza F Poli F Grubert F Wieland T Graf E Hallmayer J Strom TM Mignot E Mutations in DNMT1 cause autosomal dominant cerebellar ataxia deafness and narcolepsy Hum Mol Genet 2012 May 15 21 10 2205 10 https profiles stanford edu emmanuel mignot a href Template Cite web html title Template Cite web cite web a Missing or empty title help Breakthrough Prizes in Life Sciences 2023 Selected Publications Stanford School of Medicine Center for Narcolepsy Archived from the original on January 11 2012 Retrieved August 7 2012 PubMed Search for Emmanuel Mignot Retrieved 14 July 2022 Further reading editBassetti Claudio Billiard Michel Mignot Emmanuel eds December 21 2006 Narcolepsy and Hypersomnia 1st ed Informa Healthcare ISBN 978 0849337154 External links editOfficial website Retrieved from https en wikipedia org w index php title Emmanuel Mignot amp oldid 1222901397, wikipedia, wiki, book, books, library,
